A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma is one of the most common malignant tumors with a very high mortality rate. The emergence of immunotherapy has brought hope for the cure of hepatocellular carcinoma. Only a small number of patients respond to immune checkpoint inhibitors, and ferroptosis and tert...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Ye, Li, Jianhui, Wu, Wenlong, Guo, Dongnan, Lei, Xinjun, Zhang, Tianchen, Wang, Yanfang, Mao, Zhenzhen, Zhang, Xuan, Song, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479152/
https://www.ncbi.nlm.nih.gov/pubmed/34604045
http://dx.doi.org/10.3389/fonc.2021.706915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479152/
https://www.ncbi.nlm.nih.gov/pubmed/34604045
http://dx.doi.org/10.3389/fonc.2021.706915

Ejemplares similares